Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Gross Margin (2009 - 2026)

Charles River Laboratories International (CRL) posted Gross Margin of 45.02% for Q2 2026, up 15.88% on a QoQ basis from 38.85% in Q1 2026, and up 169.0% year-over-year from 16.74% in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Gross Margin (2009 - 2026) Analysis & Trends

Charles River Laboratories International has reported Gross Margin for 18 years, with the latest figure at 45.02% in Q2 2026.

  • On a quarterly basis, Gross Margin rose 169.0% year-over-year to 45.02% in Q2 2026; TTM through Jun 2026 was 42.15%, a 401.0% decrease from a year earlier, with the FY2025 full-year figure at 42.35%, up 27.0% from the prior year.
  • Gross Margin was 45.02% for Q2 2026 at Charles River Laboratories International, up from 38.85% in the prior quarter.
  • The five-year high for Gross Margin was 68.57% in Q4 2023, with the low at 34.09% in Q1 2024.
  • Average Gross Margin over 5 years is 43.59%, with a median of 42.35% recorded in 2025.
  • The sharpest annual moves came in 2023 and 2025: Gross Margin surged 2341 bps in 2023, then slumped 2381 bps in 2025.
  • Over 5 years, Gross Margin stood at 45.16% in 2022, then soared by 52 bps to 68.57% in 2023, then retreated by 4 bps to 65.5% in 2024, then slumped by 36 bps to 41.68% in 2025, then grew by 8 bps to 45.02% in 2026.
  • The last three Gross Margin figures came in at 45.02% (Q2 2026), 38.85% (Q1 2026), and 41.68% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 32.85%
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 28.51%
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 23.23%
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 45.02%
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 20.52%
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 91.47%
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 50.54%
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 58.58%
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 45.02%
Mar 28, 2026 38.85%
Dec 27, 2025 41.68%
Sep 27, 2025 43.01%
Jun 28, 2025 43.33%
Mar 29, 2025 41.33%
Dec 28, 2024 65.50%
Sep 28, 2024 34.56%
Jun 29, 2024 34.47%
Mar 30, 2024 34.09%
Dec 30, 2023 68.57%
Sep 30, 2023 35.25%
Jul 1, 2023 37.64%
Apr 1, 2023 36.69%
Dec 31, 2022 45.16%
Sep 24, 2022 46.35%
Jun 25, 2022 46.29%
Mar 26, 2022 46.73%
Dec 25, 2021 48.28%
Sep 25, 2021 47.69%